Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence

Abstract Nebulised unfractionated heparin (UFH) has a strong scientific and biological rationale and warrants urgent investigation of its therapeutic potential, for COVID-19-induced acute respiratory distress syndrome (ARDS). COVID-19 ARDS displays the typical features of diffuse alveolar damage wit...

Full description

Bibliographic Details
Main Authors: Frank M. P. van Haren, Clive Page, John G. Laffey, Antonio Artigas, Marta Camprubi-Rimblas, Quentin Nunes, Roger Smith, Janis Shute, Mary Carroll, Julia Tree, Miles Carroll, Dave Singh, Tom Wilkinson, Barry Dixon
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Critical Care
Subjects:
COVID-19
ARDS
SARS
Nebulised heparin
Unfractionated heparin
SARS-CoV-2
Online Access:http://link.springer.com/article/10.1186/s13054-020-03148-2

Internet

http://link.springer.com/article/10.1186/s13054-020-03148-2

Similar Items